C3 and neoplasm: COLEC12 could reduce TLR4 expression, weaken NF‐κB and C3 signaling pathway to release inflammatory factors downstream, restrain immune defense to tumor cells, inhibit apoptosis of tumor cells, and cut down lives of mouses.